BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu Z, Li J, Chen J, Shan Q, Dai H, Xie H, Zhou L, Xu X, Zheng S. MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S/G2 cell cycle progression. BMC Cancer 2018;18:200. [PMID: 29463213 DOI: 10.1186/s12885-018-4056-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Exposito F, Villalba M, Redrado M, de Aberasturi AL, Cirauqui C, Redin E, Guruceaga E, de Andrea C, Vicent S, Ajona D, Montuenga LM, Pio R, Calvo A. Targeting of TMPRSS4 sensitizes lung cancer cells to chemotherapy by impairing the proliferation machinery. Cancer Letters 2019;453:21-33. [DOI: 10.1016/j.canlet.2019.03.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
2 Niu Y, Shan L, Gao H, Zhang C, Qian Z, Wang Z, Xu X, Zhang X, Wang J, Ma L, Chen L, Yu Y. Huaier Suppresses the Hepatocellular Carcinoma Cell Cycle by Regulating Minichromosome Maintenance Proteins. Onco Targets Ther 2020;13:12015-25. [PMID: 33244243 DOI: 10.2147/OTT.S279723] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Sun J, Li P, Yang J. Repressing of NHERF1 inhibits liver cancer progression by promoting the production of ROS. Biochem Biophys Res Commun 2019;509:8-15. [PMID: 30581004 DOI: 10.1016/j.bbrc.2018.11.121] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Hou JY, Wu HY, He RQ, Lin P, Dang YW, Chen G. Clinical and prognostic value of chaperonin containing T-complex 1 subunit 3 in hepatocellular carcinoma: A Study based on microarray and RNA-sequencing with 4272 cases. Pathol Res Pract 2019;215:177-94. [PMID: 30473171 DOI: 10.1016/j.prp.2018.11.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chen S, Zhang Y, Ding X, Li W. Identification of lncRNA/circRNA-miRNA-mRNA ceRNA Network as Biomarkers for Hepatocellular Carcinoma. Front Genet 2022;13:838869. [PMID: 35386284 DOI: 10.3389/fgene.2022.838869] [Reference Citation Analysis]
6 Han W, Wu YZ, Zhao XY, Gong ZH, Shen GL. Integrative Analysis of Minichromosome Maintenance Proteins and Their Prognostic Significance in Melanoma. Front Oncol 2021;11:715173. [PMID: 34490114 DOI: 10.3389/fonc.2021.715173] [Reference Citation Analysis]
7 Quan L, Qian T, Cui L, Liu Y, Fu L, Si C. Prognostic role of minichromosome maintenance family in multiple myeloma. Cancer Gene Ther 2020;27:819-29. [PMID: 31959909 DOI: 10.1038/s41417-020-0162-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Xiong J, Xiong S, Feng X, Zhang H, Su Q, Parameshachari BD. Identification of a 5-Nutrient Stress-Sensitive Gene Signature to Predict Survival for Colorectal Cancer. BioMed Research International 2022;2022:1-13. [DOI: 10.1155/2022/2587120] [Reference Citation Analysis]
9 Li C, Qin F, Hong H, Tang H, Jiang X, Yang S, Mei Z, Zhou D. Identification of Flap endonuclease 1 as a potential core gene in hepatocellular carcinoma by integrated bioinformatics analysis. PeerJ 2019;7:e7619. [PMID: 31534853 DOI: 10.7717/peerj.7619] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
10 Farmani AR, Mahdavinezhad F, Scagnolari C, Kouhestani M, Mohammadi S, Ai J, Shoormeij MH, Rezaei N. An overview on tumor treating fields (TTFields) technology as a new potential subsidiary biophysical treatment for COVID-19. Drug Deliv Transl Res 2021. [PMID: 34542840 DOI: 10.1007/s13346-021-01067-5] [Reference Citation Analysis]
11 Chen YR, Li YT, Wang MQ, Zhu SL. Prognostic significance and function of MCM10 in human hepatocellular carcinoma. Future Oncol 2021. [PMID: 34350781 DOI: 10.2217/fon-2021-0225] [Reference Citation Analysis]
12 Sosnowska M, Kutwin M, Strojny B, Koczoń P, Szczepaniak J, Bałaban J, Daniluk K, Jaworski S, Chwalibog A, Bielawski W, Sawosz E. Graphene oxide nanofilm and chicken embryo extract decrease the invasiveness of HepG2 liver cancer cells. Cancer Nano 2021;12. [DOI: 10.1186/s12645-020-00073-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Zhu L, Yang F, Dong L, Wang G, Li Q, Zhong C. Novel evidence of obesity paradox in esophageal adenocarcinoma: perspective on genes that uncouple adiposity from dismal outcomes. J Cancer 2022;13:436-49. [PMID: 35069893 DOI: 10.7150/jca.65138] [Reference Citation Analysis]
14 Hua S, Ji Z, Quan Y, Zhan M, Wang H, Li W, Li Y, He X, Lu L. Identification of hub genes in hepatocellular carcinoma using integrated bioinformatic analysis. Aging (Albany NY) 2020;12:5439-68. [PMID: 32213663 DOI: 10.18632/aging.102969] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
15 Wu Z, Wang Y, Li J, Wang H, Tuo X, Zheng J. MCM10 is a Prognostic Biomarker and Correlated With Immune Checkpoints in Ovarian Cancer. Front Genet 2022;13:864578. [DOI: 10.3389/fgene.2022.864578] [Reference Citation Analysis]
16 Lei Y, Wang S, Liu J, Yan W, Han P, Tian D. Identification of MCM family as potential therapeutic and prognostic targets for hepatocellular carcinoma based on bioinformatics and experiments. Life Sci 2021;272:119227. [PMID: 33607151 DOI: 10.1016/j.lfs.2021.119227] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Sun LC, Qian HX. Screening for implicated genes in colorectal cancer using whole‑genome gene expression profiling. Mol Med Rep 2018;17:8260-8. [PMID: 29658574 DOI: 10.3892/mmr.2018.8862] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
18 Schaefer-Ramadan S, Aleksic J, Al-Thani NM, Malek JA. Novel protein contact points among TP53 and minichromosome maintenance complex proteins 2, 3, and 5. Cancer Med 2022. [PMID: 35567389 DOI: 10.1002/cam4.4805] [Reference Citation Analysis]
19 Zhao Q, Zhang Y, Shao S, Sun Y, Lin Z. Identification of hub genes and biological pathways in hepatocellular carcinoma by integrated bioinformatics analysis. PeerJ 2021;9:e10594. [PMID: 33552715 DOI: 10.7717/peerj.10594] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Ji Z, Li J, Wang J. Up-regulated RFC2 predicts unfavorable progression in hepatocellular carcinoma. Hereditas 2021;158:17. [PMID: 34022962 DOI: 10.1186/s41065-021-00179-9] [Reference Citation Analysis]
21 Paulson CN, John K, Baxley RM, Kurniawan F, Orellana K, Francis R, Sobeck A, Eichman BF, Chazin WJ, Aihara H, Georg GI, Hawkinson JE, Bielinsky AK. The anti-parasitic agent suramin and several of its analogues are inhibitors of the DNA binding protein Mcm10. Open Biol 2019;9:190117. [PMID: 31409229 DOI: 10.1098/rsob.190117] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
22 Shan S, Chen W, Jia JD. Transcriptome Analysis Revealed a Highly Connected Gene Module Associated With Cirrhosis to Hepatocellular Carcinoma Development. Front Genet 2019;10:305. [PMID: 31001331 DOI: 10.3389/fgene.2019.00305] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
23 Sosnowska M, Kutwin M, Strojny B, Wierzbicki M, Cysewski D, Szczepaniak J, Ficek M, Koczoń P, Jaworski S, Chwalibog A, Sawosz E. Diamond Nanofilm Normalizes Proliferation and Metabolism in Liver Cancer Cells. Nanotechnol Sci Appl 2021;14:115-37. [PMID: 34511890 DOI: 10.2147/NSA.S322766] [Reference Citation Analysis]
24 Hao J, Deng H, Yang Y, Chen L, Wu Q, Yao P, Li J, Li B, Jin X, Wang H, Duan H. Downregulation of MCM8 expression restrains the malignant progression of cholangiocarcinoma. Oncol Rep 2021;46:235. [PMID: 34523691 DOI: 10.3892/or.2021.8186] [Reference Citation Analysis]
25 Chen X, Liu C, Zhang Z, Wang M, Guo S, Li T, Sun H, Zhang P. ZNF655 Promotes the Progression of Glioma Through Transcriptional Regulation of AURKA. Front Oncol 2022;12:770013. [PMID: 35280721 DOI: 10.3389/fonc.2022.770013] [Reference Citation Analysis]
26 Fadaka AO, Bakare OO, Sibuyi NRS, Klein A. Gene Expression Alterations and Molecular Analysis of CHEK1 in Solid Tumors. Cancers (Basel) 2020;12:E662. [PMID: 32178478 DOI: 10.3390/cancers12030662] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
27 Zhang X, Huang N, Mo L, Lv M, Gao Y, Wang J, Liu C, Yin S, Zhou J, Xiao N, Pan C, Xu Y, Dong G, Yang Z, Li A, Huang J, Wang Y, Yao Y. Global Transcriptome and Co-Expression Network Analysis Reveal Contrasting Response of Japonica and Indica Rice Cultivar to γ Radiation. Int J Mol Sci 2019;20:E4358. [PMID: 31491955 DOI: 10.3390/ijms20184358] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Wang Y, Chen H, Zhang J, Cheng ASL, Yu J, To KF, Kang W. MCM family in gastrointestinal cancer and other malignancies: From functional characterization to clinical implication. Biochim Biophys Acta Rev Cancer 2020;1874:188415. [PMID: 32822825 DOI: 10.1016/j.bbcan.2020.188415] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
29 Wan W, Shen Y, Li Q. MCM10 Acts as a Potential Prognostic Biomarker and Promotes Cell Proliferation in Hepatocellular Carcinoma: Integrated Bioinformatics Analysis and Experimental Validation. Cancer Manag Res 2020;12:9609-19. [PMID: 33116820 DOI: 10.2147/CMAR.S267493] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
30 Zhou X, Liu C, Zeng H, Wu D, Liu L. Identification of a thirteen-gene signature predicting overall survival for hepatocellular carcinoma. Biosci Rep 2021;41:BSR20202870. [PMID: 33835133 DOI: 10.1042/BSR20202870] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Yu S, Wang G, Shi Y, Xu H, Zheng Y, Chen Y. MCMs in Cancer: Prognostic Potential and Mechanisms. Anal Cell Pathol (Amst) 2020;2020:3750294. [PMID: 32089988 DOI: 10.1155/2020/3750294] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
32 Li Y, Zou J, Zhang Q, Quan F, Cao L, Zhang X, Liu J, Wu D. Systemic Analysis of the DNA Replication Regulator MCM Complex in Ovarian Cancer and Its Prognostic Value. Front Oncol 2021;11:681261. [PMID: 34178669 DOI: 10.3389/fonc.2021.681261] [Reference Citation Analysis]
33 Cheng L, Tan Z, Huang Z, Pan Y, Zhang W, Wang J. Expression Profile and Prognostic Values of Mini-Chromosome Maintenance Families (MCMs) in Breast Cancer. Med Sci Monit 2020;26:e923673. [PMID: 32830194 DOI: 10.12659/MSM.923673] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Pouget C, Hergalant S, Lardenois E, Lacomme S, Houlgatte R, Carpentier C, Dehais C, Rech F, Taillandier L, Sanson M, Appay R, Colin C, Figarella-Branger D, Battaglia-Hsu SF, Gauchotte G. Ki-67 and MCM6 labeling indices are correlated with overall survival in anaplastic oligodendroglioma, IDH1-mutant and 1p/19q-codeleted: a multicenter study from the French POLA network. Brain Pathol 2020;30:465-78. [PMID: 31561286 DOI: 10.1111/bpa.12788] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
35 Ding Z, Xiang X, Li J, Wu S. Long-term 1800MHz electromagnetic radiation did not induce Balb/c-3T3 cells malignant transformation. Electromagn Biol Med 2021;40:169-78. [PMID: 33211539 DOI: 10.1080/15368378.2020.1846194] [Reference Citation Analysis]
36 Zeng T, Guan Y, Li YK, Wu Q, Tang XJ, Zeng X, Ling H, Zou J. The DNA replication regulator MCM6: An emerging cancer biomarker and target. Clin Chim Acta 2021;517:92-8. [PMID: 33609557 DOI: 10.1016/j.cca.2021.02.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Sun R, Li S, Zhao K, Diao M, Li L. Identification of Ten Core Hub Genes as Potential Biomarkers and Treatment Target for Hepatoblastoma. Front Oncol 2021;11:591507. [PMID: 33868991 DOI: 10.3389/fonc.2021.591507] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Zhu W, Gao F, Zhou H, Jin K, Shao J, Xu Z. Knockdown of MCM8 inhibits development and progression of bladder cancer in vitro and in vivo. Cancer Cell Int 2021;21:242. [PMID: 33931059 DOI: 10.1186/s12935-021-01948-2] [Reference Citation Analysis]
39 Zhou F, Aipire A, Xia L, Halike X, Yuan P, Sulayman M, Wang W, Li J. Marchantia polymorpha L. ethanol extract induces apoptosis in hepatocellular carcinoma cells via intrinsic- and endoplasmic reticulum stress-associated pathways. Chin Med 2021;16:94. [PMID: 34583719 DOI: 10.1186/s13020-021-00504-4] [Reference Citation Analysis]
40 Ahmed MY, Salah MM, Kassim SK, Abdelaal A, Elayat WM, Mohamed DA, Fouly AE, Abu-Zahra FAE. Evaluation of the diagnostic and therapeutic roles of non-coding RNA and cell proliferation related gene association in hepatocellular carcinoma. Gene 2019;706:97-105. [PMID: 31034943 DOI: 10.1016/j.gene.2019.04.054] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
41 Guo F, Kong WN, Feng YC, Lv J, Zhao G, Wu HL, Ai L, Zhou X, Cai XL, Sun W, Ma XM. Comprehensive Analysis of the Expression and Prognosis for MCMs in Human Gastric Cancer. Technol Cancer Res Treat 2020;19:1533033820970688. [PMID: 33167799 DOI: 10.1177/1533033820970688] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Nottingham E, Mazzio E, Surapaneni SK, Kutlehria S, Mondal A, Badisa R, Safe S, Rishi AK, Singh M. Synergistic effects of methyl 2-cyano-3,11-dioxo-18beta-olean-1,-12-dien-30-oate and erlotinib on erlotinib-resistant non-small cell lung cancer cells. J Pharm Anal 2021;11:799-807. [PMID: 35028186 DOI: 10.1016/j.jpha.2021.06.002] [Reference Citation Analysis]
43 Jia W, Xie L, Wang X, Zhang Q, Wei B, Li H, Qin S, Chen S, Liu J, Tan Y, Zheng S, Liang X, Yang X. The impact of MCM6 on hepatocellular carcinoma in a Southern Chinese Zhuang population. Biomed Pharmacother 2020;127:110171. [PMID: 32403044 DOI: 10.1016/j.biopha.2020.110171] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
44 Vishnoi M, Liu NH, Yin W, Boral D, Scamardo A, Hong D, Marchetti D. The identification of a TNBC liver metastasis gene signature by sequential CTC-xenograft modeling. Mol Oncol 2019;13:1913-26. [PMID: 31216110 DOI: 10.1002/1878-0261.12533] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
45 Chen W, Zhao S, Yu W, Rao T, Ruan Y, Zhu S, Xia Y, Song H, Cheng F. SC66 inhibits the proliferation and induces apoptosis of human bladder cancer cells by targeting the AKT/β-catenin pathway. J Cell Mol Med 2021;25:10684-97. [PMID: 34687144 DOI: 10.1111/jcmm.17005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Yang J, Xie Q, Zhou H, Chang L, Wei W, Wang Y, Li H, Deng Z, Xiao Y, Wu J, Xu P, Hong X. Proteomic Analysis and NIR-II Imaging of MCM2 Protein in Hepatocellular Carcinoma. J Proteome Res 2018;17:2428-39. [DOI: 10.1021/acs.jproteome.8b00181] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
47 Umeda S, Kanda M, Kodera Y. Recent advances in molecular biomarkers for patients with hepatocellular carcinoma. Expert Rev Mol Diagn 2019;19:725-38. [PMID: 31248309 DOI: 10.1080/14737159.2019.1638254] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
48 Gao S, Zhu D, Zhu J, Shen L, Zhu M, Ren X. Screening Hub Genes of Hepatocellular Carcinoma Based on Public Databases. Comput Math Methods Med 2021;2021:7029130. [PMID: 34737790 DOI: 10.1155/2021/7029130] [Reference Citation Analysis]
49 Choong WK, Sung TY. Somatic mutation subtypes of lung adenocarcinoma in East Asian reveal divergent biological characteristics and therapeutic vulnerabilities. iScience 2021;24:102522. [PMID: 34142036 DOI: 10.1016/j.isci.2021.102522] [Reference Citation Analysis]
50 Lv W, Zhang X, Dong H, Wu Q, Sun B, Zhang Y. Exploring effects of DNA methylation and gene expression on pan-cancer drug response by mathematical models. Exp Biol Med (Maywood) 2021;246:1626-42. [PMID: 33910405 DOI: 10.1177/15353702211007766] [Reference Citation Analysis]
51 Zhang Z, He CZ, Qin YQ, Liao JJ, Huang ST, Mo S, Li HM, Lin JY. Exploring the mechanism of resistance to sorafenib in two hepatocellular carcinoma cell lines. Aging (Albany NY) 2020;12:24255-69. [PMID: 33234725 DOI: 10.18632/aging.104195] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
52 Wu N, Zhang X, Zhu M, Fang C, Liu X, Wang Y, Li H, Liu S, Ting H, Qin C, Liao Q, Cai J, Wang J. ZNF582 promoter methylation predicts cervical cancer radiosensitivity and ZNF582 protein overexpression reduces radiosensitivity by cell cycle arrest in S phase. Epigenetics 2022. [PMID: 35642528 DOI: 10.1080/15592294.2022.2080995] [Reference Citation Analysis]
53 Ye L, Zhang X, Xu Q, Cai Y, Gao W, Chen W. Anti-tumor activities and mechanism study of α-pinene derivative in vivo and in vitro. Cancer Chemother Pharmacol 2020;85:367-77. [PMID: 31797046 DOI: 10.1007/s00280-019-03997-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
54 Liang XH, Feng ZP, Liu FQ, Yan R, Yin LY, Shen H, Lu HL. Identification of potential biomarkers for diagnosis of hepatocellular carcinoma. Exp Ther Med 2022;23:51. [PMID: 34917180 DOI: 10.3892/etm.2021.10973] [Reference Citation Analysis]
55 Ren Z, Li J, Zhao S, Qiao Q, Li R. Knockdown of MCM8 functions as a strategy to inhibit the development and progression of osteosarcoma through regulating CTGF. Cell Death Dis 2021;12:376. [PMID: 33828075 DOI: 10.1038/s41419-021-03621-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Wang X, Zhang L, Song Y, Jiang Y, Zhang D, Wang R, Hu T, Han S. MCM8 is regulated by EGFR signaling and promotes the growth of glioma stem cells through its interaction with DNA-replication-initiating factors. Oncogene 2021;40:4615-24. [PMID: 34131285 DOI: 10.1038/s41388-021-01888-1] [Reference Citation Analysis]